Skip to content

A randomized, prospective, multicenter study to validate the usefulness of 3D-printing surgical guides for breast-conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy

A Randomized, prospective, multicenter trial of 3d printing, a patient-specific surgical guide for breast-conserving surgery after neoadjuvant chemotherapy: comparative evaluation according to the presence or absence of surgical guide.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0004469
Enrollment
488
Registered
2019-11-25
Start date
2019-12-09
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The experimental group applies the 3D printing breast surgery guide (3DP-BSG). 3DP-BSG is prepared based on pre- and post-treatment medical images (MRI / CT) in patients undergoing ne

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: •Female patients from 20 to 79 years of age •Patients who received or is receiving neoadjuvant chemotherapy, after diagnosed with invasive breast cancer by histology •Patients who are scheduled to have breast-conserving surgery after neoadjuvant chemotherapy •Subjects who fully understands and agrees in writing to the Informed consent form

Exclusion criteria

Exclusion criteria: • Patients who have contraindications of MRI ? Those with an inserted electrical device, clip for the prevention of aneurysm, artificial of metallic material around the eyeball ? Patients who have Claustrophobia ? Patients with difficulty using gadolinium-based angiography - severe allergic or impaired of kidney function (creatinine > 2.0) ? Pregnant • Difficult partial resection due to large calcification lesions • Patients deemed unsuitable to participate in this clinical trial at the Investigator's discretion

Design outcomes

Primary

MeasureTime frame
Tumor at first resection margin

Secondary

MeasureTime frame
Distance from tumor to edge of specimen;Volume of the removed specimen;Weight of removed specimen;Surgery time;Patient satisfaction;Surgeon's Satisfaction

Countries

Korea, Republic of

Contacts

Public ContactMunju Jeong

Asan Medical Center

mjoo0608@gmail.com+82-2-3010-6194

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 12, 2026